Login
$CCCC
$2.63 -$0.02 (0.75%) After hours

Ownership

13F as of Q2 2026 · 136.1M shares outstanding

Who owns CCCC?

By type of holder
Institutions 84.9% Insiders 6.6% Everyone else 8.4%
Concentration Top 10 holders own 46.4%
Morgan Stanley 6.5% · Ra Capital Management, L.P. 5.9%
Institutional ownership
84.9%
+22.8 pts vs last qtr
Institutional holders
145
+22 vs last qtr
Net shares bought
+31.1M
by institutions in Q2 2026
New / sold out
51 / 29
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • BlackRock, Inc. +5.8M
  • Squadron Capital Management LLC +5.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Susquehanna International Group, LLP SOLD OUT −1.3M
  • Renaissance Technologies LLC −1.3M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$2.47M
6 notices from 3 people
Shares covered
231.5K
0.17% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$1.0M$2.1MDecJanFebMar 2026: $378.8K without a planMarAprMay 2026: $35.5K without a planMayJunJulAug 2026: $2.1M without a planAugSepOctNov
Largest proposed sellers
  • Jay Geldmacher Former rezi ceo $1.9M
  • Jolie M Siegel Officer $379K

Sign up to see all 3.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+629.0%
+48.78% a year
Each share's claim on the business
−86.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$691K vs $131M
over 6 fiscal years
Diluted shares, split-adjusted
11.0M47.4M83.7M2020: 11.4M shares'202021: 46.0M shares'212022: 48.9M shares'222023: 49.6M shares'232024: 69.4M shares'242025: 82.9M shares'25
Buybacks Stock-based comp
$0$15.0M$30.0M2020 buybacks: $194.0K2020 stock comp: $3.4M'202021 buybacks: $02021 stock comp: $21.5M'212022 buybacks: $02022 stock comp: $30.0M'222023 buybacks: $110.0K2023 stock comp: $27.2M'232024 buybacks: $194.0K2024 stock comp: $29.7M'242025 buybacks: $193.0K2025 stock comp: $19.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years49% 3–5 years3% 1–3 years13% Under 1 year34%
Quarterly turnover
30.2%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting CCCC on Form 13F
MS
Morgan Stanley
Shares
8.9M
% of company
6.52%
Change vs last qtr
−205.1K (−2.3%)
Held since
≤2021
RC
Ra Capital Management, L.P.
Shares
8.0M
% of company
5.88%
Change vs last qtr
Unchanged
Held since
Q4 '25

28 more super investors behind a free account

See every manager holding C4 Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CCCC on Form N-PORT; together they hold 15.3% of the company
VT
Position value
$15.2M
% of company
2.40%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$12.1M
% of company
1.91%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding C4 Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
CM
Cohen Marc A
Insider
Shares
2.9M
% of company
2.17%
Change vs last qtr
—
Held since
—
CA
Cohen Alain J
Insider
Shares
2.5M
% of company
1.85%
Change vs last qtr
—
Held since
—

10 more holders behind a free account

See every insider and 5%+ holder of C4 Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support